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Abstract
This study investigated the relationship between the type of material and the
concentration of IgA in human milk stored at two temperatures over time. Twelve breastfeeding
mothers participated in the study with samples of milk obtained at locations of the participant’s
preference and transported to the laboratory in a sterile Snappies PP container stored in a cooler
filled with ice. The sample was divided up and pipetted into 12 containers. IgA concentrations
were determined by enzyme-linked immunosorbent assay at time zero, 9, 24, 48, 72 and 168
hours. Milk IgA concentration decreased in all containers, with the exception of polycarbonate
from 72 hours to 168 hours in -20°C. In 4°C, the results of IgA concentrations showed volatility
and did not indicate a stable trend. The data suggested that the concentration of milk IgA was
more affected by temperature and the type of material may not have a significant impact on IgA.
The data also indicated a maximum storage length of three days in refrigerators to maintain IgA
levels.
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Introduction
In present-day America, women are returning to their jobs earlier after giving birth than previous
generations who took longer maternity leaves. Those who choose to breastfeed, find it nearly
impossible to feed their infants during their work hours so they must pump then store milk in
containers in refrigerators and freezers. Stored milk is then used to feed infants when the women
are at work or away from their infants. As a result, it is increasingly difficult for mothers to
follow the American Academy of Pediatrics (AAP)’s recently amended recommendation that
mothers breastfeed their infants for at least one year. At least 50 percent of women who are
employed when they become pregnant return to work by the time their children are three months
old, making this study important to analyze the effects of storage time and temperature
conditions normally found in refrigerators and freezers (Tyler, 2000). Fortunately, refrigerators
and freezers are available to give mothers the option of storing their milk for future feedings to
ensure their infants receive milk when breastfeeding is inconvenient or not possible. Ideally,
stored milk should be identical to freshly expressed milk in terms of concentration and viability
of different biocomponents. It is even more critical for infants in a Neonatal Intensive Care Unit
(NICU) to have their mothers pump the optimal milk so they receive the highest quantity of
immunologic factors. One in eight babies are born prematurely and placed in the NICU due to
the rising number of twins and triplets from assisted reproduction, induced premature deliveries,
and Cesarean sections (Maugh, 2008). It is publicized that the colostrum of mothers of preterm
infants has higher concentrations of IgA, up to 12 g/L to 0.5-1.0 g/L in mature milk (Butte et al.,
1984) or 310.5 mg/g in preterm colostrum compared to 168.2 mg/g in term colostrum (Groer &
Walker, 1996; Gross et al., 1981a).
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Previous studies in the last 30 years show that human milk loses important components
due to a variety of factors, including temperature and adherence of components to the materials
of the storage containers. In a groundbreaking study by Goldblum et al. (1981), the
concentration of secretory IgA in milk is shown to have no change in glass and polypropylene.
However, in a report by Williamson and Murti (1996), there is a loss of IgA in glass with the
mean count of IgA in human milk stored in glass decreasing after seven hours. SIgA is stable in
rigid polyethylene containers, but is reduced by 60 percent after being stored in flexible
polyethylene bags (Goldblum et al., 1981).
IgA has been selected as the milk component for analysis because several lactation
consultants and experts recommended IgA due to its important role in the immune system of the
nursing infant (Lactnet postings, 11-27-08 to 12-4-08). An additional feature is that IgA is found
to be stable at 4°C and -20°C (Evans, Ryley, Neale, Dodge, & Lewarne, 1978, Pardou, Serruys,
Mascart-Lemone, Dramaix, & Vis, 1994). Lawrence and Lawrence (2005) recommends up to 48
hours of milk storage in the refrigerator and up to six months in a standard home freezer.

Purpose of the Thesis
This project will study different storage container materials to find the minimum impact
on the adherence of IgA in human milk by quantifying the loss of IgA due to adherence. The
goal is to show whether current recommendations proposed by lactation consultants and doctors
regarding container types, temperature, and time are still appropriate for optimal levels of IgA.
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IgA and sIgA
IgA antibodies are the first line of defense against a wide berth of pathogens in the human
body.

They bind to bacteria and toxins, preventing them from invading epithelial cells;

particularly in the mucus epithelium of the intestinal and respiratory tracts. By preventing these
microbes, no inflammation is induced as other antibodies and phagocytes are not activated (Hale
& Hartmann, 2007). IgA also neutralize toxins or bacteria by absorption. There are two forms of
IgA found in the human body; the first is monomeric IgA with a molecular weight of 160 kDa
and the second is the 390 kDa dimeric type. The dimeric form is two monomeric IgA linked by
a J-chain by disulfide bonds (Janeway, Travers, White & Shlomachik, 2001).

Figure 1. sIgA with J Chain and Secretory Component
(http://www.phasmatodea.org/ap2/immunology2_notes.html)
IgA in the blood system is mainly monomeric, whereas in the mucosal linings, IgA is
usually in the dimeric form, (Janeway et al., 2001). The dimeric form is referred to as secretory
IgA (sIgA) and is the principal isotype in infants as sIgA can be transported across the epithelium
from the mother’s mammary glands to the milk. It is the predominant antibody in human milk,
making up 80 to 90% of the antibodies in the colostrum and mature milk (Hale & Hartmann,
2007).

In the lactating mammary gland, plasma cells synthesize IgA under the basement
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membrane with two IgA antibodies binding them to a J chain. A complex of the J-chain and IgA
antibodies attaches to a poly-Ig receptor and diffuses across the basement membrane. After
being transported through the basement membrane, sIgA enters the mammary gland, which
produces human milk and is later lactated to the feeding infant (Janeway et al., 2001).

Figure 2. Transport of sIgA through the secretory epithelium via three methods
(http://www.med.uio.no/rh/patologi/liipat/secretory_immunity/pictures/TIfig1big.htm)
The role of sIgA is vital to the infant as it plays different functions in the intestinal
development of neonates, including promoting intestinal adaptation to extrauterine life and
establishment of beneficial microbiota. It also prevents infection and inflammation as well as
compensates for the developmental immaturity of the intestine (Donovan, 2006). In infants,
sIgA is effective against enterotoxin-producing E. coli, Campylobacter, Shigella, salmonellae,
streptococci, staphylococci, and pneumococci (Glass et al., 1983; Ruiz-Palacios et al., 1990;
Hayani et al., 1992; Cruz et al., 1983; Waterspiel et al., 1994). SIgA is also shown to be active
against a large range of viruses, such as polio virus types 1, 2, 3, coxsackie virus types, ECHO
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virus types 6, 9, as well as rotaviruses (Welsh & May, 1979). The infant does not attain adult
levels of IgA until two months old.
IgA and sIgA is shown to be unaffected by freezing for four weeks (Tully, Jones & Tully,
2001). Cycles of freezing/thawing do not affect the composition of IgA (Evans, Ryley, Neale,
Dodge, & Lewarne, 1978, Pardou, Serruys, Mascart-Lemone, Dramaix, & Vis, 1994).
However, it is possible that sIgA proteins may undergo protein denaturalization during thawing
after being frozen (Kerner, Quan, Yang et al., 1987). The average concentration of IgA in human
milk quantified by the ELISA technique during the first year of lactation is approximately 0.388
to 1.105 grams per liter (g/L) (Weaver, Arthur, Bunn, & Thomas, 1997). The results from
O’Connor, Schmidt, Carroll-Pankhurst, and Olness (1998) show a range of 0.32 to 0.49 g/l of
sIgA in human milk using the radial immunodiffusion technique.

Packaging Materials
The following human milk storage containers are chosen for their material composition:
1. Medela Freezing and Storage rigid polypropylene 80 mL bottles- 090607-A part 61095 100
2. Snappies sterile rigid polypropylene 70 mL containers- Lot 071107 Part 10253 Mold #252
3. Ameda rigid polycarbonate milk bottles – Lot 7J058
4. Medela Pump and Save flexible polyethylene (HDPE) storage bags- Lot 39209A 73321
5. Ball canning glass- 14400-80400, 05-604
6. Axifeed rigid polyethylene (HDPE) 100 mL sterile bottles- Lot 121865
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Material Characteristics
There are four different materials being examined in the thesis: polypropylene,
polycarbonate, high density polyethylene, and glass. There are two types of plastics. The first
type of plastics is flexible yielding materials, such as film, foil, or paper sheeting, which acquire
a pliable shape when filled and sealed. The Medela flexible polyethylene bag falls under this
category. The second group is rigid packaging, which maintains its shape and dimensions
throughout its lifecycle after thermoformed. All rigid plastic containers belong to this category.
Polypropylene (PP), identified by Resin Identification Code #5, is used in food packaging
applications, including take-out containers, lids and domes, cups, tubs for yogurt and margarine,
ketchup bottles, and medicine bottles. They are also utilized for housewares, media packaging,
bottles for cosmetics and household industrial chemicals, plastic syringes, and air/water filtration
systems. The advantages of PP are that bottles can be hot-filled and may have a built-in handle.
The material has excellent optical clarity in biaxially-oriented films and can be injection molded,
thermoformed, and stretch blow molded. They have low moisture vapor transmission, and are
inert to acids, alkalis, and most solvents. The density of polypropylene used for bottles, labels,
and clear films is low, approximately 0.89 to 0.93 grams/ cm3. Polypropylene’s low specific
gravity and good stiffness can result in fewer pounds of resin used per thousand packaging units,
saving costs to the manufacturer.

There are no known safety concerns or worries about

consumer applications.
Polycarbonate (PC) is identified by Resin Identification Code #7 and is used in medical
devices. It is also used for containers, such as reusable/microwaveable housewares and reusable
bottles, which include water cooler bottles, sports bottles, and baby bottles. PC is commonly
blended with other plastics. Additionally, PC is a durable plastic that can withstand relatively
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high temperatures; hence, it is an ideal choice for applications requiring frequent reuse and
washing, sterilizing or microwave heating (PlasticsEurope, 2008). The advantages
polycarbonate provides are toughness, dimensional stability, optical clarity, high heat resistance,
and excellent electrical resistance. PC is also recyclable, and is a high-value resin for recycling
due to its relatively high cost per pound of resin (PlasticsEurope, 2008). The cost factors
discourage the use of polycarbonate in packaging and other single-use applications. PC is
portrayed negatively in the public eye due to a monomer, known as bisphenol A or BPA, from
which PC is manufactured. However, the Food and Drug Administration, the EU Scientific
Committee on Food, and the Japanese Ministry of the Environment have determined the amount
of residual BPA in PC to be typically less than 50 parts-per-million, declaring PC safe for use
(FDA, 2008).
High density polyethylene (HDPE) is identified by Resin Identification Code #2; it is
known for its low cost in manufacturing. It also has an excellent moisture barrier and does not
typically break when dropped. The disadvantages of HDPE are its permeability to oxygen and a
high cold-flow rate (Soroka, 2002).
Glass is usually created from combining silica sand mixed with carbonates, such as
limestone, soda ash, or alumina in high heat. Advantages of using glass include its inertness to
most chemicals. In addition, glass does leach out materials, altering the taste of food. Glass has
excellent impermeability to oxygen for long-term storage of products sensitive to oxygen. It is
also stable at high temperatures and maintains a rigid shape. The disadvantages of using glass
are its brittleness, which makes glass prone to breaking at specific heights. It is also more
expensive to manufacture than plastic resins (Soroka, 2002).
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Company’s Criteria for Selecting a Material for Their Storage Containers
Companies manufacturing bottles used in the thesis were contacted by e-mail. This
e-mail included questions on why the company chose the specific material for their containers.
Only two companies, Medela and Snappies, responded.
Snappies
Nancy Fleming, the Commercial Product Manager for the Snappies container at Thermo
Fisher Scientific, responded to my e-mail inquiry about the selection of PP in Snappies
containers. The company chose polypropylene because most of the company’s other products
are made from polypropylene. As a result, Thermo Fisher Scientific had a strong relationship
with its resin supplier. They also had previous packaging experience when working in the dairy
industry prior the company entering the human milk market. Their results showed that milk fat
did not stick to polypropylene, leading to more consistent results in testing.

From the

manufacturing perspective, the suppliers and mold engineers chose polypropylene because
human milk needed to be stored in a food-grade plastic container. They also wanted a resin that
could flow through the injection-molding equipment and had a low-residual odor.
Medela
Simdon Craig, the Product Introduction Engineer at Medela, responded to my e-mail
about their selection of materials in their two containers. Craig mentions their bottles were not
regulated medical devices; hence, they did not consider them to be measurement devices. For
the Medela flexible polyethylene bags, Craig indicated that the company uses a HDPE inner liner
due to its food contact properties and water vapor barrier properties. They chose this resin for
their rigid PP containers over other resins, indicating previous studies showing PP as a good
material for storing human breast milk. Medela chose polypropylene for its translucent clarity
8

and its ability to withstand cleaning and sterilization requirements FDA requires. Medela also
made a decision ten years ago to not use PC in their containers as the company was aware of the
leaching of bisphenol A into liquids.

Hypothesis
Rigid PP containers will be the optimal storage containers for the least IgA retention at
4˚C and -20˚C. Rigid PP containers will be followed by other materials in order from best to
worst performance in least retention of IgA in 4˚C and -20˚C, HDPE, glass, PC, and flexible PP
bags.
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Method / Acquirement of Samples
1. The RIT Human Subjects Research Office has approved the participation of human subjects.
2.

Lactation consultants, clubs, and organizations targeting new moms, along with word-ofmouth have been used to contact possible candidates.

3.

Eligibility for the project has been determined based on voluntary participation and
willingness to donate milk 4 to 30 weeks post-delivery. Ideally, the number of participants
was 20 to 25 to achieve statistical significance.

4. Participants were briefed on the study goals, risks, and privacy issues before voluntarily
agreeing to sign an Informed Consent form prior to participation.
5.

Information on the age of mothers and that of their infants were taken to explain possible
outliers that may appear in the data analysis.

6. The researcher went to locations of the participant’s preference to collect human milk.
7.

Sterile Snappies polypropylene containers were used to collect each participant’s milk.

8. A single expression of milk from one or both breasts, by breast pump or hand expression,
were collected in a sterile Snappies polypropylene tube.
9. Breast milk samples were labeled at the site with a reference number to protect the identity of
the participant. The sample was transported to RIT, chilled in a cooler filled with ice.
10. The reference numbers and names were kept in a safe in Professor Deanna Jacobs’ office,
70-1313 in the Golisano College of Computing and Information Sciences.
11. The reference number used for each participant was not published in the thesis. Letters (A,
B, and C) were used in the published data to protect the identity of the participants.
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12. After arriving in the lab, time zero was established when the sample in the Snappies
polypropylene bottle was shaken and three 800-microliter aliquots of the sample were placed
in separate 1.5 mL centrifuge tubes. The average of the three was the benchmark for IgA
levels at time zero.
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Transferring Breast Milk from Snappies Transport Container
to the Appropriate Containers
1. 60 mL of milk received from participants were pipetted from the Snappies transport
container to the different containers involved in the experiment. Each container had 5 mL of
sample.
2. There were 12 containers altogether. One of each type of container was stored in the
refrigerator and one in the freezer, which resulted in six containers in the refrigerator and six
in the freezer.
3. The containers were placed next to each other in the same area in the freezer/fridge to reduce
variability due to location of samples.
4. For the refrigerated samples, three different aliquots were taken from each container and
combined to make one sample at 9, 24, 48, and 72 hours. Frozen samples were analyzed at
72 and 168 hours. Each container was warmed under warm running water 45 seconds for
refrigerated samples and 130 seconds for frozen samples.
5. Warming of the refrigerated and frozen samples followed the standard procedure provided by
lactation consultants on thawing milk and were applied to all containers in this experiment in
the previous step.
6. 800 microliters of milk for each container were measured and centrifuged in the tabletop
centrifuge (MicroSpin 12, Sorvall Instruments) for 20 minutes. 400 microliters of the bottom
whey layer were pipetted and placed into a centrifuge tube. The top layer, compromised of
cream, was discarded. Appropriate dilution of 1:2 or 1:4 of each sample combined with
sample diluent was performed.
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Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol
1. For the ELISA procedure, the Bethyl Laboratories E80-102 manual was referenced.
2. A change was made at the end of Step B1 in the Bethyl manual. Instead of following
Bethyl’s recommendation of washing the wells by aspirating each well, the “flick and tap”
method was used.
3. The samples were diluted by a factor of 2 or 4 in Step B2. This was done as previous
literature showed the average concentration of IgA to be approximately 700 ng/mL, As a
result, 1:2 dilutions were performed to ensure the samples fit the standard curve of 7.8 ng/ml
to 1000 ng/ml.
4. The substrate’s reaction with 3, 3’, 5, 5’-tetramethylbenzidine (TMB) wells were read by an
at ELISA ELx800 UV reader (Bio-Tek Instruments) at 450 nm.
5. KC Junior (Bio-Tek) was used to convert absorbance readings into IgA concentrations by
comparing the samples to the standards provided by Bethyl.
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Table 1. A Sample Set Up of a 96-Well ELISA Plate

A

B

C

D

1

2

1000

Blank

ng/mL
standard

3

4

5

6

7

8

9

10

11

12

Blank

Blank

1000

Empty

Empty

Empty

Empty

Empty

Empty

Empty

(sample

(sample

diluent)

diluent)

(sample

ng/mL

well

well

well

well

well

well

well

diluent)

standard

500

Ameda

ng/mL

Bottle

Ameda

Ameda

500

Empty

Empty

Empty

Empty

Empty

Empty

Empty

Bottle

Bottle

ng/mL

well

well

well

well

well

well

well

standard

Sample

Sample

Sample

standard

250

Snappies

Snappie

Snappies

Bottle

s Bottle

Bottle

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty

ng/mL
standard

Sample

Sample

Sample

250
ng/mL
standard

125

Medela

Medela

Medela

PP Bottle

PP

PP Bottle

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty

ng/mL
standard

Sample

Bottle

Sample

125
ng/mL
standard

62.5
ng/mL
standard

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty

31.5
ng/mL
standard

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty

15.625
ng/mL
standard

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty

7.8
ng/mL
standard

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty
well

Empty

well

well

Sample
E

F

G

H

62.5

Medela

Medela

Medela

ng/mL

HDPE

HDPE

HDPE

standard

Bottle

Bottle

Bottle

Sample

Sample

Sample

31.25

Axifeed

Axifeed

Axifeed

ng/mL

Bottle

Bottle

Bottle

standard

Sample

Sample

Sample

15.625

Ball

Ball

Ball

ng/mL

Glass

Glass

Glass

standard

Sample

Sample

Sample

7.8

Blank

Blank

Blank

ng/mL

(sample

(sample

(sample

standard

diluent)

diluent)

diluent)

well

well

well

well

Legend: The table shows the set up of blanks, standards, and samples in a 96- well plate. There are two replicates
of each standard and three replicates of each sample.
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Statistical Methods
1. For each subject, the numbers of replicates at time zero were averaged together. The average
became the baseline for all replicates at each time point compared.
2. The standard deviation from the baseline was determined for elimination of outliers.
3. Individual replicates for each container were compared to the baseline. If a replicate showed
a concentration higher than the standard deviation range, then it was omitted from the results.
4. The remaining replicates were divided by the baseline and converted to a percentage.
5. The percentages were added to represent an average percentage for each container at each
time point.
6. The subjects were added together to create the final percent of IgA remaining in milk in each
container at every time point.
7. Each container was plotted onto a line graph with the X-axis values representing percent of
IgA in milk and the Y-axis values representing hours.
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Results
Twelve subjects participated in the study, with four subjects excluded from the results
due to contamination of the samples during the data-gathering process. Contamination occurred
during time zero and nine hours, with the samples assumed to be compromised when the blanks
had larger readings than the background readings. In a few cases, the blanks were shown to have
absorbance values as high as the samples. If the blanks displayed high absorbance values, then
the standard curves created from the known standards provided by Bethyl, Inc could not be
established. This led to the omission of the samples at that specific time point from the study.
The subjects used in the study were labeled as B through L. The range of time from lactation of
the milk to the laboratory was anywhere from 15 minutes to one hour and 15 minutes. Most
samples had a transportation average time of 30 to 35 minutes. There were six time points (0, 9,
24, 48, 72, and 168 hours) and two temperatures (4 °C and -20 °C) in the data. As seen in Table
2, the mean standard deviation of samples taken at time zero was 338.5 with a high value of
697.6 and a low value of 122.4.
Table 2. Age of Mother and Infant with Mean IgA Concentration at Time Zero
Subject

Age of Subject

Age of Infant

Mean IgA Concentration

Standard Deviation

(ng/ml)
B

29 years

4 weeks

1892.3

697.6

C

30 years

5 weeks

3116.9

122.4

1889.3

312.7

F
H

30 years

28 weeks

3081.5

525.3

I

27 years

9 weeks

1062.5

263.1
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Subject

Age of Subject

Age of Infant

Mean IgA Concentration

Standard Deviation

(ng/ml)
J

33 years

44 weeks

3198.0

355.0

K

32 years

4 weeks

1051.0

196.1

L

30 years

28 weeks

1231.1

235.7

Nine-hour values are not included in the results for subjects B, I, and K, In addition,
subject F’s 48 and 72-hour marks are omitted from the results. Subjects H, J, and L do not have
their 24-hour values in their results. Subject H does not include values from 48 hours. The
omitted values are ignored because the wells at these time points showed inconsistent results due
to contamination of the samples from human error or the researcher’s technique.
Table 3 shows how many samples were used to represent the amount of IgA remaining in
the human milk over time. The nine-hour mark has an unbalanced number of samples because
the Snappies and Axifeed containers have one extra sample. The 24-hour mark has only three
samples and the 48-hour mark has five samples. The 72-hour samples and the 168-hour samples
have seven subjects. The higher number of subjects in the 72-hour and 168-hour samples
compared to the earlier time points is due to reliable standard curves and the low absorbance
values from the blanks.
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Table 3. The Number of Samples in Each Container used in the Data.

4°C

Ameda PC

Rigid
Medela PP
bottle

Snappies PP

Medela
Flexible PE
Bag

Axifeed HDPE

Ball Glass

9 hours

4

5

4

4

5

4

24 hours

3

3

3

3

3

3

48 hours

5

5

5

5

5

5

72 hours

7

7

7

7

7

7

Ameda PC

-20°C

Rigid
Medela
PP bottle

Snappies PP

Medela
Flexible PE
Bag

Axifeed
HDPE

Ball Glass

72 hours

7

7

7

7

7

7

168 hours

7

7

7

7

7

7

Legend: Each value represents the number of subjects used to represent the data.

Tables 5 and 6 include the average percentage of IgA concentration remaining in each
container compared to the baseline of IgA quantified at time zero. The last two rows of the tables
show the average of all time points for each container as well as the standard deviation.

18

Table 4. Percentages of IgA Concentration Quantified in Human Milk Stored at 4°C

Hours

Ameda
PC

Snappies
PP

Medela
PP
container

Medela
Flexible
PE Bag

Axifeed
HDPE

Ball
Glass

9

76.16

71.92

72.33

72.26

71.47

69.38

24

76.53

85.43

83.15

71.59

79.85

78.24

48

73.39

74.52

71.88

78.32

76.99

73.38

72

82.71

74.34

76.61

76.16

78.53

81.68

Average

77.20

76.55

75.99

74.58

76.71

75.67

Standard
Deviation

23.54

22.12

20.67

15.98

22.88

18.69

Table 5. Percentages of IgA Concentration Quantified in Human Milk Stored at -20°C

Hours

Ameda
PC

Snappies
PP

Medela
PP
container

Medela
Flexible
PE Bag

Axifeed
HDPE

Ball
Glass

72

83.29

83.37

85.25

90.20

89.06

86.30

168

84.40

82.72

82.85

84.55

85.94

82.09

Average

83.84

83.04

84.05

87.37

87.50

84.19

Standard
Deviation

20.48

18.94

16.90

15.66

15.47

21.01

Figures 3 and 4 are a visual representation of Tables 4 and 5, which show the
concentrations of IgA varying from temperature to temperature as well as container to container.
In the -20°C freezer at 72 hours (Figure 3), all containers performed very close to each other,
ranging from 83.3% of IgA in the Ameda PC container to 90.2% of IgA left in human milk in
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the Medela PE bag. The concentration of IgA reduces in all containers from 72 hours to 168
hours, with the exception of Ameda, which remains stable. The range varies from 85.9% in
Axifeed to 82.1% in glass. None of the containers went below 80% at -20°C in both time points.
Figure 4 shows how each material performs in the least retention of IgA in the 4°C
samples. The IgA concentration starts out low at nine hours and steadily increases to 24 hours in
all containers, with the exception of Medela PE bags and Ameda PC containers.

IgA

concentration drops down at 48 hours for all containers, with the exception of Medela PE bags,
which increases from 71.6 to78.3%. There are mixed results in IgA concentration in different
materials at 72 hours. For all 4°C samples, there is consistency in the performance of all
containers throughout the duration of the experiment as the range of IgA concentration goes from
69% to 85% as compared to the original concentration. The worst performing container is the
Ball glass with 69.4% of IgA in the human milk at nine hours compared to time zero. The best
performing material is the Medela PE bag with 85.4% of IgA in the human milk at 24 hours.
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Figure 3. Percentage of IgA Remaining in Human Milk Stored in the Freezer (-20°C).

Legend: Percentage of IgA in the samples taken from bottles since time zero. Two time points are used to analyze
the -20°C (freezer) samples.
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Figure 4. Percentage of IgA Remaining in Human Milk Stored in the Refrigerator (4°C).

Legend: Percentage of IgA in the samples taken from bottles since time zero. Four time points are used to analyze
the 4°C (refrigerator) samples.

Further statistical analysis was performed on the 72 hour mark to compare the influence
of the material on IgA stored at 4°C and -20°C. It was the only time point when both the
refrigerator and freezer samples were present.

Eight subjects were used to compare both

temperatures. These subjects were B, C, F, H, I, J, K, and L.
Table 6 shows the results of the concentration of IgA at 72 hours.
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Table 6. Concentration of IgA (ng/ml) in Each Container Stored at 4°C and -20°C for 72
Hours.
Mean
Ameda PC

Snappies PP
Medela Rigid
PP
Medela
Flexible PE

Axifeed HDPE

Glass

Standard
Deviation Minimum

Median

Maximum

-20°C

1887

1071

841

1323

3942

4°C

1792

883

846

1429

4892

-20°C

1751

942

841

1337

4054

4°C

1533

501

736

1679

2449

-20°C

1761

887

773

1477

3205

4°C

1710

871

609

1393

3882

-20°C

1944

1065

737

1394

4156

4°C

1522

488

699

1456

2365

-20°C

2170

1421

829

1697

5615

4°C

1542

517

845

1451

2648

-20°C

1971

1303

345

1360

5862

4°C

1586

494

716

1571

2321

Legend: Three observations were made for each container. Design was unbalanced as Subject K in the Snappies PP
and Subject I in the Medela Flexible PE at 4°C had only two observations, so the third observation came from the
mean of the first two observations.

The first significant analysis demonstrated that each container had a higher mean in the
-20°C as compared to 4°C; however, the median was lower in -20°C for all containers. The
Axifeed HDPE and the Medela PP containers had higher means and median in the freezer. The
standard deviation was higher in the freezer for all containers.
The next significant observation was the interaction of three variables: temperature,
subject, and container (see Table 7). When the subjects were random with the container and
temperature values being fixed, the temperature (p=0.277) and subject (p =0.050) were more
significant on influencing the concentration of IgA than the container (p=0.521). There was a
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strong interaction between the subjects and temperatures (p=0.00) when compared against the
interaction of containers and temperatures (p=0.168).
Table 7. Interaction of Different Subjects, Containers, and Temperatures at 72 Hours.
Source

P-value

Source

P-value

SubjectA_72

0.050

SubjectA_72

0.050

Container_72

0.521

Container_72

0.514

Temp_72

0.277

Temp_72

0.277

SubjectA_72*Temp_72

0.000

SubjectA_72*Temp_72

0.000

Container_72*Temp_72

0.168
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Discussion
The transportation method was derived from the study by Goldblum et al. (1981). The
method varied a little as their study mentioned the collection of milk usually took ten minutes
with transportation in 4°C in an ice chest to the laboratory. The participant contributed two
times for the study; one sample was stored in a Pyrex glass cylinder while the other sample was
stored in a polyethylene container. In this study, only one contribution was taken from each
participant with the average transportation time taking 30 minutes. The sample was stored in a
polypropylene container rather than a Pyrex glass cylinder and a polyethylene container. The
study by Friend, Shahani, Long, and Vaughn (1983) was also referenced as the researchers
collected milk at participants’ houses and traveled to the laboratory. The decision of starting
time zero in this study was based on the Friend et al study, where their experiment started at the
point they arrived at their laboratory.
Different subjects had different concentrations of IgA ranging from 1051.0 to 3198.0
ng/ml (Table 2). Previous literature noted different variables may affect the concentration of IgA
in different women, including environmental stresses, the health of mother and infant, and the
week of gestational age of the infant (Weaver et al., 1998, & Goldman et al., 1982, & Prentice,
Prentice, & Cole, 1984, & Hennart, Brasseur, Delgone-Desnoeck et al., 1991). The standard
deviation of the subjects at time zero (338.5 ng/ml) was shown to be less than the published
standard deviation of 1360 ng/ml (1.360 g/l) in the paper of Koenig, Diniz, Barbosa, and Vaz
(2005). The smaller standard deviation was encouraging; indicating that the data obtained in this
experiment may have been more consistent than previous studies.
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The technique used in the experiment may have led to the inconsistency of the results
from the samples. It is strongly believed the inconsistency of samples in the shorter time points
was due to lack of concentration or drowsiness when working in the lab nine to twelve hours in
the first 24 hours of experiment for each subject. The 48, 72, and 168 hours may have come out
better due to more time apart between experiments.
The sample size in the study is very small, creating a higher volatility in the data as
compared to larger sample sizes. For instance, only three out of eight subjects were used in the
4°C samples at the 24-hour mark, while the nine-hour and 48-hour marks included four or five
subjects. This could explain why most of the containers increased at least 5% from the nine-hour
mark to 24-hour mark while the percentage decreased at least 5% at the 48 hour mark. Even
with a small sample size and a large range of high and low values in each container, the average
of all percentages for each container showed each container performed very consistently
throughout the duration of the experiment. When all the containers were compared to each
other, they essentially performed very closely, with a range of 74.6 to 77.2% in the 4°C samples
and 83.0 to 87.5% in the -20°C samples.
It is exciting to show a material did not retain more than 20% of the original
concentration in the -20°C samples. Further, it was encouraging to know that loss of
concentration was not necessarily directly related to the retention of the IgA by the material, but
rather attributed to the protein denaturalization that may occur during the thawing process as
noted in the study by Kerner et al. (1987). When the 20°C samples were compared to the 4°C
samples, there was less loss of IgA in the human milk, supporting Lawrence and Lawrence
(2005)’s recommendation that frozen samples may be left for six months.
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Further research, however, must be taken to study to determine whether the length of
duration is still appropriate for maintaining IgA levels. This could mean the lower temperature
may be more optimal in terms of IgA remaining inside the milk. A lower temperature may be
credited with less movement of IgA; thus, reducing the material and IgA interaction.
Alternatively, a lower temperature may prevent the degradation of IgA as microbes reproduce at
a faster rate in 4°C as compared to -20°C.
A surprising finding indicated the concentration of IgA found in PE bags in the freezer
and refrigerator is drastically higher than reported in earlier studies, which showed PE losing up
to 60% of sIgA antibodies specific for E.coli during storage (Arnold, 1995). This may be
attributed to Medela adding a HDPE inner lining to the PE bag. It is also possible that the
performance of the PE bag has improved over 20 years with the addition of HDPE linings.
The 72-hour statistical analysis comparing the refrigerator and freezer samples indicated
the null hypothesis demonstrated a strong correlation of temperature and subject interaction, with
little, if any, influence from the containers. Figures 2 and 3 as well as the statistical analysis
showed less IgA loss in the freezer. The p-values showed no specific type of material made a
significant difference on the retention of IgA, disproving the hypothesis that loss of IgA was
attributed to the retention of IgA by the material in the container.
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Conclusion
The Rigid PP containers were not the optimal storage containers in both temperatures,
which disproved the hypothesis. HDPE (Axifeed) performed the best while Rigid PP (Snappies
and Medela) fared the worst in -20°C. At 4°C, there was no clear evidence to confirm the best
performing material.
The decrease of IgA from 72 hours to 169 hours may be attributed to IgA degradation as
the 168 hour samples went through two thawing cycles as compared to one thawing cycle for the
72 hour samples. As a result, the impact of the IgA concentration may be from the extra
freezing/thawing cycles; not from time.
The current recommendations of the lactation consultants and doctors are still practical
after seeing these results. An important issue is to prove is whether temperature is a greater
influence on IgA levels. Women do not need to worry about the container they use to achieve the
best results in terms of protecting one biocomponent of human milk studied in this thesis.
Further, mothers do not need to concern themselves with the selection of the optimal container in
terms of preserving IgA levels. Rather, mothers are encouraged to focus more important factors,
including the ease of the container for the infant and mother; the shelf space available in the
refrigerator and freezer; and the compatibility of the container with the breast pump. Results
indicate that three days is the maximum length of time for storing breast milk in refrigerators. If
mothers do not expect to use their milk within three days, then they should place the milk in the
freezer.
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Limiting Factors
The small number of samples used in the experiment is the limiting factor, discouraging
the significance of the results. More samples are needed to prove whether the results from the
experiment maintain the same trend for a larger population. However, results presented from
this research is a good indication that storage container material may not be the primary factor
causing decreased levels of IgA, but rather degradation may be attributed to temperature. With
the data seen in this experiment, the next step is to study a larger collection of human milk to
support or disprove the results found in this study.
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Appendix A - Consent Form
Matthew Jenkins
Packaging Science Dept.
Email: mdj7463@rit.edu
Thank you for agreeing to participate in this study which will take place from 3/10/08 to 6/20/08.
This form outlines the purposes of the study and provides a description of your involvement and
rights as a participant.
The purposes of this project are:
1.) To gain insight into the topic of the influence of different milk containers on the retention of
an immune protein called Immunoglobulin A in breast milk stored several days in the
refrigerator and freezer after pumping.
The methods used to collect information are explained below:
A. 20 mothers who are feeding their infants with breast milk 4 to 30 weeks after delivery
will voluntarily give breast milk once or twice during the study.
B. A single pump from both breasts, either by breast pump or hand, will be placed in a
sterile container provided by the researcher.
C. That is all that is required from you, the milk will be taken to a biology laboratory at RIT
where it will be analyzed for the amount of IgA.
You are encouraged to ask any questions anytime about the nature and goals of this study and the
methods that I am using. Your suggestions and concerns are very important to me so please
contact me at any time at the email address listed at the top of the paper.
I will use the data from your milk sample along with other samples to write about the influence
of storage container materials, including glass and different plastics, IgA. I will send a copy of
my final thesis if you want to see it.
Your personal information will be kept confidential.
This copy is to be signed by you and for the researcher to keep:
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I guarantee that the following conditions will be met:
1.) Your real name will not be used at any point of information collection after the donation of
your milk. The written records, data, and final thesis will only use letters to represent you.
2.) Your participation in this research is voluntary; you have the right to withdraw at any point
of the study, for any reason, and without any prejudice, and the information collected from
you will be omitted from the study.
3.) You may ask for a copy of the published thesis for you to keep.

Do you grant permission to donate your breast milk and have it analyzed by me, Matthew
Jenkins?

Yes_____________

No ___________

By signing this, you are agreeing to the terms written above:

Respondent __________________________________________
Date ______________

Researcher_____________________________________________
Date ______________
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Appendix B - Background Information Form

Participant’s Name:

__________________________________________

Age:

G

How many weeks or months have passed since your delivery?

__________________________________________
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